Received Feb 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Shingrixout of recommended storage temperatures for more than 6 hours; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: Shingrixout of recommended storage temperatures for more than 6 hours). The outcome of the incorrect storage of drug was unknown. Additional Information: GSK receipt date: 16-JAN-2025 The reporter called to report leaving Shingrix vaccine out of recommended storage temperatures for more than 6 hours which led to, incorrect storage of drug.